Related Experiment Video
Updated: Aug 4, 2025

10:12
Characterization and Functional Prediction of Bacteria in Ovarian Tissues
Published on: October 23, 2021
2.8K
Role of the Microbiome in Malignancy
Frederick A Godley1, Benjamin D Shogan1, Neil H Hyman1
1Department of Surgery, The University of Chicago Medicine, Chicago, Illinois, USA.
Surgical Infections
|April 3, 2023
Summary
The human microbiome, or oncobiome, influences cancer risk across many organs. Understanding these microbe-driven mechanisms offers new diagnostic and therapeutic strategies for cancer prevention and treatment.
Area of Science:
- Microbiology
- Oncology
- Gastroenterology
Background:
- The human microbiome plays a crucial role in maintaining health and disease.
- An expanding understanding links the microbiome to carcinogenesis across various organs.
- The term 'oncobiome' describes the maladaptive microbiome's role in cancer development.
Purpose of the Study:
- To explore the mechanisms by which the microbiome influences carcinogenesis.
- To highlight the potential of targeting the oncobiome for cancer prevention and therapy.
- To use colorectal malignancy as a model to demonstrate the microbiome's role.
Main Methods:
- Review of existing literature on microbiome and cancer.
- Analysis of mechanisms including microbe-driven inflammation and mucosal failure.
- Exploration of diet-induced microbiome derangement.
Main Results:
- The resident microbiota is uniquely tied to malignancy risks in organs like the colon, lungs, pancreas, ovaries, cervix, and stomach.
- Maladaptive microbiome aspects are increasingly linked to cancer in other organs.
- Mechanisms such as inflammation and mucosal protection failure are key influencers of cancer risk.
Conclusions:
- The oncobiome represents a significant factor in cancer development.
- Modifying the oncobiome offers potential diagnostic and therapeutic interventions.
- Targeting microbiome-related pathways could interrupt cancer progression.
Related Concept Videos
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Microorganisms in Medicine and Therapeutics
94
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
94
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

